We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+7.24%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$2.14B
AUM Growth
+$218M
Cap. Flow
+$172M
Cap. Flow %
8.07%
Top 10 Hldgs %
26.01%
Holding
154
New
13
Increased
61
Reduced
17
Closed
10

Sector Composition

Rank Sector Weight
1 Healthcare 38.18%
2 Technology 17.61%
3 Consumer Discretionary 12.18%
4 Industrials 9.62%
5 Utilities 3.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLKN icon
126
MillerKnoll
MLKN
$1.61B
$1.3M 0.06%
40,800
+9,100
+29% +$345K
APU
127
DELISTED
AmeriGas Partners, L.P.
APU
$1.28M 0.06%
32,000
+7,000
+28% +$311K
CCI.PRA
128
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
$1.11M 0.05%
990
+235
+31% +$258K
CVA
129
DELISTED
Covanta Holding Corporation
CVA
$1.07M 0.05%
73,500
+32,800
+81% +$517K
CWEN icon
130
Clearway Energy Class C
CWEN
$4.9B
$1.04M 0.05%
61,000
+29,700
+95% +$521K
VTR icon
131
Ventas
VTR
$47.7B
$966K 0.05%
19,500
+9,600
+97% +$503K
WELL icon
132
Welltower
WELL
$172B
$958K 0.04%
17,600
+8,750
+99% +$494K
VYNE icon
133
VYNE Therapeutics
VYNE
$19.1M
$940K 0.04%
+7
New +$851K
GPMT
134
Granite Point Mortgage Trust
GPMT
$63.3M
$918K 0.04%
+55,500
New +$954K
WBK
135
DELISTED
Westpac Banking Corporation
WBK
$887K 0.04%
40,000
+5,900
+17% +$141K
CIG icon
136
CEMIG Preferred Shares
CIG
$6.21B
$864K 0.04%
657,203
+78,472
+14% +$93.6K
ERIC icon
137
Ericsson
ERIC
$32.7B
$736K 0.03%
115,000
+20,000
+21% +$135K
LXP icon
138
LXP Industrial Trust
LXP
$3.53B
$630K 0.03%
16,000
+5,000
+45% +$213K
EIGR
139
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$621K 0.03%
2,100
-2,067
-50% -$611K
LPT
140
DELISTED
Liberty Property Trust
LPT
$616K 0.03%
15,500
+3,500
+29% +$141K
AYI icon
141
Acuity Brands
AYI
$10.3B
$564K 0.03%
4,050
+750
+23% +$115K
BCRX icon
142
BioCryst Pharmaceuticals
BCRX
$2.48B
-290,000
Closed -$1.42M
CDTX
143
DELISTED
Cidara Therapeutics
CDTX
-8,600
Closed -$1.17M
PBYI icon
144
Puma Biotechnology
PBYI
$406M
-20,000
Closed -$1.98M
PTGX icon
145
Protagonist Therapeutics
PTGX
$8.8B
-275,000
Closed -$5.72M
SAGE
146
CALL
DELISTED
Sage Therapeutics
SAGE
-100,000
Closed -$16.5M
TCON
147
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
-4,500
Closed -$3.02M
NTUS
148
DELISTED
Natus Medical Inc
NTUS
-75,000
Closed -$2.87M
TTPH
149
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
-23,185
Closed -$2.92M
ACHN
150
DELISTED
Achillion Pharmaceuticals
ACHN
-850,000
Closed -$2.45M

Similar funds

Eventide Asset Management's Q1 2018 Portfolio in Review

As of Q1 2018, Eventide Asset Management held 154 positions worth $2.14B, up 11% from $1.92B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Eventide Asset Management deployed $172M of net new capital in Q1 2018, opening 13 new positions and adding to 61 existing holdings. Its largest new stake was Arista Networks: 1,056,000 shares worth $16.9M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 37% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Trade Desk, an estimated $16.9M trimmed.

  • Eventide Asset Management's largest Q1 2018 buy was Arista Networks: 1,056,000 shares worth $16.9M.
  • Eventide Asset Management added most to GTT Communications, Inc. in Q1 2018, an estimated $19.7M increase.
  • Eventide Asset Management's biggest Q1 2018 reduction was Trade Desk, cutting an estimated $16.9M.
  • Eventide Asset Management fully exited Protagonist Therapeutics in Q1 2018, selling an estimated $5.72M.
  • Eventide Asset Management's ten largest holdings make up 26% of its $2.14B portfolio in Q1 2018.
  • Eventide Asset Management opened 13 new positions and closed 10 in Q1 2018.
  • Eventide Asset Management's portfolio value rose 11% quarter-over-quarter to $2.14B.

Based on Eventide Asset Management's 13F filing for Q1 2018, filed 15 May 2018.